BUFFALO, N.Y., April 25, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies ...

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with ...

HOUSTON--(BUSINESS WIRE)--Kuur Therapeutics, a leader in the development of off-the-shelf CAR-NKT cell immunotherapies for the treatment of hematological and solid malignancies, today announced the ...

SEATTLE--(BUSINESS WIRE)--AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study, AVM0703-001, entitled “The WWRD Study: AVM0703 for Treatment ...

You have full access to this article via your institution. Our second discovery began with the analysis of the thymic development of NKT cells in the Vβ8.2-F108Y mice, which displayed a unique ...

Fred Hutch researchers pioneered bone marrow transplantation, one of the most significant advances in treating lymphoma, leukemia and other blood cancers. We continue to improve bone marrow and blood ...

Results from five patients showed best responses of 2 partial responses (PR), 1 complete response with incomplete hematological recovery (CRi) and 1 complete response (CR). Updated data show continued ...